162 related articles for article (PubMed ID: 29080080)
21. Ubiquitin C-terminal hydrolases cleave isopeptide- and peptide-linked ubiquitin from structured proteins but do not edit ubiquitin homopolymers.
Bett JS; Ritorto MS; Ewan R; Jaffray EG; Virdee S; Chin JW; Knebel A; Kurz T; Trost M; Tatham MH; Hay RT
Biochem J; 2015 Mar; 466(3):489-98. PubMed ID: 25489924
[TBL] [Abstract][Full Text] [Related]
22. Essential role of maternal UCHL1 and UCHL3 in fertilization and preimplantation embryo development.
Mtango NR; Sutovsky M; Susor A; Zhong Z; Latham KE; Sutovsky P
J Cell Physiol; 2012 Apr; 227(4):1592-603. PubMed ID: 21678411
[TBL] [Abstract][Full Text] [Related]
23. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
[TBL] [Abstract][Full Text] [Related]
24. Emerging roles of deubiquitinating enzymes in human cancer.
Yang JM
Acta Pharmacol Sin; 2007 Sep; 28(9):1325-30. PubMed ID: 17723166
[TBL] [Abstract][Full Text] [Related]
25. Deubiquitinases and the new therapeutic opportunities offered to cancer.
Pfoh R; Lacdao IK; Saridakis V
Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
[TBL] [Abstract][Full Text] [Related]
26. The new function of two ubiquitin C-terminal hydrolase isozymes as reciprocal modulators of germ cell apoptosis.
Kwon J
Exp Anim; 2007 Apr; 56(2):71-7. PubMed ID: 17460351
[TBL] [Abstract][Full Text] [Related]
27. UCH-L3 structure and function: Insights about a promising drug target.
Hafez N; Modather El-Awadly Z; Arafa RK
Eur J Med Chem; 2022 Jan; 227():113970. PubMed ID: 34752952
[TBL] [Abstract][Full Text] [Related]
28. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S
Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin carboxyl-terminal hydrolases are required for period maintenance of the circadian clock at high temperature in Arabidopsis.
Hayama R; Yang P; Valverde F; Mizoguchi T; Furutani-Hayama I; Vierstra RD; Coupland G
Sci Rep; 2019 Nov; 9(1):17030. PubMed ID: 31745110
[TBL] [Abstract][Full Text] [Related]
30. Two closely related ubiquitin C-terminal hydrolase isozymes function as reciprocal modulators of germ cell apoptosis in cryptorchid testis.
Kwon J; Wang YL; Setsuie R; Sekiguchi S; Sato Y; Sakurai M; Noda M; Aoki S; Yoshikawa Y; Wada K
Am J Pathol; 2004 Oct; 165(4):1367-74. PubMed ID: 15466400
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.
Rong C; Zhou R; Wan S; Su D; Wang SL; Hess J
Front Oncol; 2020; 10():592501. PubMed ID: 33585209
[TBL] [Abstract][Full Text] [Related]
32. Localization of ubiquitin C-terminal hydrolase L1 in mouse ova and its function in the plasma membrane to block polyspermy.
Sekiguchi S; Kwon J; Yoshida E; Hamasaki H; Ichinose S; Hideshima M; Kuraoka M; Takahashi A; Ishii Y; Kyuwa S; Wada K; Yoshikawa Y
Am J Pathol; 2006 Nov; 169(5):1722-9. PubMed ID: 17071595
[TBL] [Abstract][Full Text] [Related]
33. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
34. Multiple ubiquitin C-terminal hydrolases from chick skeletal muscle.
Woo SK; Lee JI; Park IK; Yoo YJ; Cho CM; Kang MS; Ha DB; Tanaka K; Chung CH
J Biol Chem; 1995 Aug; 270(32):18766-73. PubMed ID: 7642526
[TBL] [Abstract][Full Text] [Related]
35. Protein deubiquitination during oocyte maturation influences sperm function during fertilisation, antipolyspermy defense and embryo development.
Yi YJ; Sutovsky M; Song WH; Sutovsky P
Reprod Fertil Dev; 2015 Nov; 27(8):1154-67. PubMed ID: 24848520
[TBL] [Abstract][Full Text] [Related]
36. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.
Jang MJ; Baek SH; Kim JH
Cancer Lett; 2011 Mar; 302(2):128-35. PubMed ID: 21310527
[TBL] [Abstract][Full Text] [Related]
37. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.
Wang KK; Yang Z; Sarkis G; Torres I; Raghavan V
Expert Opin Ther Targets; 2017 Jun; 21(6):627-638. PubMed ID: 28434268
[TBL] [Abstract][Full Text] [Related]
39. The de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signaling.
Hussain S; Foreman O; Perkins SL; Witzig TE; Miles RR; van Deursen J; Galardy PJ
Leukemia; 2010 Sep; 24(9):1641-55. PubMed ID: 20574456
[TBL] [Abstract][Full Text] [Related]
40. Ubiquitin carboxyl-terminal hydrolase isozyme L5 inhibits human glioma cell migration and invasion via downregulating SNRPF.
Ge J; Hu W; Zhou H; Yu J; Sun C; Chen W
Oncotarget; 2017 Dec; 8(69):113635-113649. PubMed ID: 29371935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
